Skip to content
Ejaculation.org

Review · 2016

The Drug Treatment of Delayed Ejaculation

Abdel-Hamid IA, Elsaied MA, Mostafa T (2016). The Drug Treatment of Delayed Ejaculation. Translational Andrology and Urology. doi:10.21037/tau.2016.05.05

Key finding
This review lists many drugs tried for delayed ejaculation, including testosterone, cabergoline, bupropion, amantadine, cyproheptadine and pseudoephedrine, but finds the evidence limited to small trials, case series and case reports.

Summary

The authors searched several databases from 1966 to February 2016 for studies on drug treatment of delayed ejaculation (DE), also called retarded or inhibited ejaculation. They describe DE as uncommon, challenging to treat and often concerning for the men affected.

Drugs that have been used include testosterone, cabergoline, bupropion, amantadine, cyproheptadine, midodrine, imipramine, ephedrine, pseudoephedrine, yohimbine, buspirone, oxytocin and bethanechol. Despite this long list, the evidence is limited to small trials, case series and case reports. Double-blind randomised trials existed only for testosterone, oxytocin, buspirone and bethanechol. The authors conclude that successful drug treatment of DE is "still in its infancy" and that the choice of drug needs to be individualised.

Limitations

This is a narrative review without pooled analysis. Most of the underlying studies are small, and several drugs were studied mainly in men whose delay was caused by antidepressants.

What it means for you

There is no proven pill for delayed ejaculation. A doctor may try a medicine off-label in specific situations, for example when an antidepressant is the cause, but treating the cause and sex therapy remain the backbone of treatment.